|
L3MBTL3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.655900E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.832200E-02 |
| Normal-vs-Stage2 |
8.899900E-03 |
| Normal-vs-Stage3 |
1.491530E-02 |
| Normal-vs-Stage4 |
3.834300E-04 |
| Stage1-vs-Stage2 |
8.045600E-02 |
| Stage1-vs-Stage3 |
2.808200E-01 |
| Stage1-vs-Stage4 |
1.833780E-02 |
| Stage2-vs-Stage3 |
4.078600E-01 |
| Stage2-vs-Stage4 |
8.548200E-01 |
| Stage3-vs-Stage4 |
2.245200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.644100E-04 |
| Normal-vs-AfricanAmerican |
4.447600E-01 |
| Normal-vs-Asian |
4.708200E-02 |
| Caucasian-vs-AfricanAmerican |
1.655390E-01 |
| Caucasian-vs-Asian |
1.437520E-02 |
| AfricanAmerican-vs-Asian |
1.014440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.770300E-04 |
| Normal-vs-Female |
1.337400E-01 |
| Male-vs-Female |
3.468000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.916000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.794300E-02 |
| Normal-vs-Age(61-80Yrs) |
6.411100E-04 |
| Normal-vs-Age(81-100Yrs) |
4.848200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.216000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.107500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.780100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.079170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.326100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.282440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.950000E-01 |
| Normal-vs-Grade 2 |
2.097400E-01 |
| Normal-vs-Grade 3 |
2.184500E-04 |
| Normal-vs-Grade 4 |
1.156550E-03 |
| Grade 1-vs-Grade 2 |
2.032600E-01 |
| Grade 1-vs-Grade 3 |
1.620040E-02 |
| Grade 1-vs-Grade 4 |
1.876160E-02 |
| Grade 2-vs-Grade 3 |
4.724300E-03 |
| Grade 2-vs-Grade 4 |
9.001300E-03 |
| Grade 3-vs-Grade 4 |
4.874600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.919700E-02 |
| Normal-vs-ccB subtype |
3.935600E-02 |
| ccA subtype-vs-ccB subtype |
9.253000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.770100E-02 |
| Normal-vs-N1 |
1.126490E-02 |
| N0-vs-N1 |
2.837000E-01 |
|
|
